PlainBillCongress, translated.Legislation. Context. Public interest.Referred to House Ways and Means
Congressional Research Service
Version 00 · Introduced in House · Dec 16, 2010
Improving Care for Kidney Patients Act of 2010 - Amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act with respect to kidney disease benefits.
Sets at 100% the federal medical assistance percentage (FMAP) with respect to the placement of an arteriovenous fistula or graft in the hemodialysis treatment of Medicaid beneficiaries.
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Agency for Healthcare Research and Quality, to study and report to Congress on: (1) the social, behavioral, and biological factors leading to kidney disease; (2) efforts to slow the progression of kidney disease in minority populations that are disproportionately affected by it; and (3) research gaps in the development of quality measures and care management for patients with end-stage renal disease (ESRD), including pediatric patients.
Showing the opening paragraphs of the official summary.
Amends the Social Security Act, with respect to criminal penalties for certain acts, to exclude from the meaning of illegal remuneration the waiver of any fee or cost-sharing by a renal dialysis facility (RDF) in providing chronic kidney disease screening that meets certain criteria.
Treats as a hospital for Medicare purposes an institution providing Medicare or Medicaid patients diagnosed with stage IV or stage V kidney disease with educational materials about treatment. Treats as a person qualified to furnish kidney disease education services an RDF meeting specified criteria.
Makes eligible to participate in a shared savings program as an accountable care organization (ACO) a group consisting of RDFs, nephrologists, and other service providers and suppliers that treat patients with kidney disease.
Prescribes Medicare requirements for coordination of care between hospitals and RDFs for the discharge planning process for an ESRD patient.
Specifies Medicare coverage to specialized occlusive dressings used by a patient receiving dialysis treatment for protection against life threatening catheter-related infections during maintenance of personal hygiene at home.
Directs the Comptroller General to evaluate and report to Congress on the transportation barriers facing dialysis patients that result in less than 100% compliance with a Medicare plan of care.
Directs the Secretary, in specified circumstances, to accept the results of a state licensure survey for purposes of determining federal certification of an RDF's compliance with the conditions of Medicare participation.
Directs the Secretary of HHS to report to Congress on the benefits of recognizing dialysis vascular and peritoneal dialysis access care service sites in order to receive Medicare reimbursement.
Revises Medicare requirements for group health plans to: (1) extend the period during which they are primary payers (and Medicare the secondary payer) for ESRD patients; and (2) prohibit denial of a Medigap policy to a ESRD patient.
Amends the Public Health Service Act, as amended by the Patient Protection and Affordable Care Act, to allow a group health plan or health insurance issuer to impose restrictions for kidney failure treatment on a participant, beneficiary, or enrollee only if they are reasonable and assure adequate access to out-of-network providers.
People & committees
Rep. Lewis, John [D-GA-5] · D–GA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to House Ways and Means
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to House Energy and Commerce
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 14, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.6537 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.6537 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.6537 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.6537 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.